p53-dependent apoptotic mechanism of a new designer bimetallic compound tri-phenyl tin benzimidazolethiol copper chloride (TPT-CuCl2): in vivo studies in Wistar rats as well as in vitro studies in human cervical cancer cells. [electronic resource]
- The Journal of pharmacology and experimental therapeutics Oct 2004
- 22-33 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0022-3565
10.1124/jpet.104.069104 doi
Animals Apoptosis Apoptosis Regulatory Proteins Carrier Proteins--metabolism Caspase 3 Caspases--metabolism Cell Division--drug effects Cytochromes c--metabolism Down-Regulation Enzyme Activation Female HeLa Cells Humans Inhibitor of Apoptosis Proteins Intracellular Signaling Peptides and Proteins Membrane Proteins--metabolism Microtubule-Associated Proteins--metabolism Mitochondria--drug effects Mitochondrial Proteins--metabolism Neoplasm Proteins Organotin Compounds--pharmacology Papillomaviridae--drug effects Proto-Oncogene Proteins c-bcl-2--metabolism Rats Rats, Wistar Survivin Tumor Suppressor Protein p53--metabolism Uterine Cervical Neoplasms--pathology bcl-2 Homologous Antagonist-Killer Protein bcl-2-Associated X Protein